128 related articles for article (PubMed ID: 15483092)
1. Endocrine and immunogenetic testing in individuals with type 1 diabetes and 21-hydroxylase autoantibodies: Addison's disease in a high-risk population.
Barker JM; Ide A; Hostetler C; Yu L; Miao D; Fain PR; Eisenbarth GS; Gottlieb PA
J Clin Endocrinol Metab; 2005 Jan; 90(1):128-34. PubMed ID: 15483092
[TBL] [Abstract][Full Text] [Related]
2. DRB1*04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease.
Yu L; Brewer KW; Gates S; Wu A; Wang T; Babu SR; Gottlieb PA; Freed BM; Noble J; Erlich HA; Rewers MJ; Eisenbarth GS
J Clin Endocrinol Metab; 1999 Jan; 84(1):328-35. PubMed ID: 9920103
[TBL] [Abstract][Full Text] [Related]
3. Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes.
Triolo TM; Baschal EE; Armstrong TK; Toews CS; Fain PR; Rewers MJ; Yu L; Miao D; Eisenbarth GS; Gottlieb PA; Barker JM
J Clin Endocrinol Metab; 2009 Nov; 94(11):4517-23. PubMed ID: 19820007
[TBL] [Abstract][Full Text] [Related]
4. Predicting the onset of Addison's disease: ACTH, renin, cortisol and 21-hydroxylase autoantibodies.
Baker PR; Nanduri P; Gottlieb PA; Yu L; Klingensmith GJ; Eisenbarth GS; Barker JM
Clin Endocrinol (Oxf); 2012 May; 76(5):617-24. PubMed ID: 22066755
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features.
Myhre AG; Undlien DE; Løvås K; Uhlving S; Nedrebø BG; Fougner KJ; Trovik T; Sørheim JI; Husebye ES
J Clin Endocrinol Metab; 2002 Feb; 87(2):618-23. PubMed ID: 11836294
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against glutamic acid decarboxylase and 21-hydroxylase in Brazilian patients with type 1 diabetes or autoimmune thyroid diseases.
Silva RC; Sallorenzo C; Kater CE; Dib SA; Falorni A
Diabetes Nutr Metab; 2003 Jun; 16(3):160-8. PubMed ID: 14635733
[TBL] [Abstract][Full Text] [Related]
7. Genetic determinants of 21-hydroxylase autoantibodies amongst patients of the Type 1 Diabetes Genetics Consortium.
Baker P; Fain P; Kahles H; Yu L; Hutton J; Wenzlau J; Rewers M; Badenhoop K; Eisenbarth G
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1573-8. PubMed ID: 22723331
[TBL] [Abstract][Full Text] [Related]
8. Dominant suppression of Addison's disease associated with HLA-B15.
Baker PR; Baschal EE; Fain PR; Nanduri P; Triolo TM; Siebert JC; Armstrong TK; Babu SR; Rewers MJ; Gottlieb PA; Barker JM; Eisenbarth GS
J Clin Endocrinol Metab; 2011 Jul; 96(7):2154-62. PubMed ID: 21565792
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison's disease and autoimmune polyendocrine syndrome type II.
Seissler J; Schott M; Steinbrenner H; Peterson P; Scherbaum WA
Exp Clin Endocrinol Diabetes; 1999; 107(3):208-13. PubMed ID: 10376448
[TBL] [Abstract][Full Text] [Related]
10. HLA similarities indicate shared genetic risk in 21-hydroxylase autoantibody positive South African and United States Addison's disease.
Ross IL; Babu S; Armstrong T; Zhang L; Schatz D; Pugliese A; Eisenbarth G; Baker Ii P
Tissue Antigens; 2014 Oct; 84(4):361-9. PubMed ID: 25040682
[TBL] [Abstract][Full Text] [Related]
11. II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease.
Betterle C; Volpato M; Rees Smith B; Furmaniak J; Chen S; Zanchetta R; Greggio NA; Pedini B; Boscaro M; Presotto F
J Clin Endocrinol Metab; 1997 Mar; 82(3):939-42. PubMed ID: 9062510
[TBL] [Abstract][Full Text] [Related]
12. Low dose (1 microg) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's disease.
Laureti S; Arvat E; Candeloro P; Di Vito L; Ghigo E; Santeusanio F; Falorni A
Clin Endocrinol (Oxf); 2000 Jul; 53(1):107-15. PubMed ID: 10931087
[TBL] [Abstract][Full Text] [Related]
13. 21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Belgian Diabetes Registry.
Falorni A; Laureti S; Nikoshkov A; Picchio ML; Hallengren B; Vandewalle CL; Gorus FK; Tortoioli C; Luthman H; Brunetti P; Santeusanio F
Clin Exp Immunol; 1997 Feb; 107(2):341-6. PubMed ID: 9030873
[TBL] [Abstract][Full Text] [Related]
14. I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease.
Betterle C; Volpato M; Rees Smith B; Furmaniak J; Chen S; Greggio NA; Sanzari M; Tedesco F; Pedini B; Boscaro M; Presotto F
J Clin Endocrinol Metab; 1997 Mar; 82(3):932-8. PubMed ID: 9062509
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease.
Gambelunghe G; Falorni A; Ghaderi M; Laureti S; Tortoioli C; Santeusanio F; Brunetti P; Sanjeevi CB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3701-7. PubMed ID: 10523017
[TBL] [Abstract][Full Text] [Related]
16. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
El-Amir MI; El-Feky MA; Laine AP; Härkönen T; El-Badawy O; Eltayeb AA; El-Melegy TT; Kiviniemi M; Knip M; Ilonen J
Diabetes Metab Res Rev; 2015 Mar; 31(3):287-94. PubMed ID: 25256132
[TBL] [Abstract][Full Text] [Related]
17. Steroid 21-hydroxylase autoantibodies: measurements with a new immunoprecipitation assay.
Tanaka H; Perez MS; Powell M; Sanders JF; Sawicka J; Chen S; Prentice L; Asawa T; Betterle C; Volpato M; Smith BR; Furmaniak J
J Clin Endocrinol Metab; 1997 May; 82(5):1440-6. PubMed ID: 9141530
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against recombinant human steroidogenic enzymes 21-hydroxylase, side-chain cleavage and 17alpha-hydroxylase in Addison's disease and autoimmune polyendocrine syndrome type III.
de Carmo Silva R; Kater CE; Dib SA; Laureti S; Forini F; Cosentino A; Falorni A
Eur J Endocrinol; 2000 Feb; 142(2):187-94. PubMed ID: 10664529
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure.
Chen S; Sawicka J; Betterle C; Powell M; Prentice L; Volpato M; Rees Smith B; Furmaniak J
J Clin Endocrinol Metab; 1996 May; 81(5):1871-6. PubMed ID: 8626850
[TBL] [Abstract][Full Text] [Related]
20. Adrenal-cortex autoantibodies and steroid-producing cells autoantibodies in patients with Addison's disease: comparison of immunofluorescence and immunoprecipitation assays.
Betterle C; Volpato M; Pedini B; Chen S; Smith BR; Furmaniak J
J Clin Endocrinol Metab; 1999 Feb; 84(2):618-22. PubMed ID: 10022426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
